par Rossi, Maxime ;Roumeguere, Thierry
Référence Drug Design, Development and Therapy, 4, page (291-297)
Publication Publié, 2010
Article révisé par les pairs
Titre:
  • Silodosin in the treatment of benign prostatic hyperplasia.
Auteur:Rossi, Maxime; Roumeguere, Thierry
Informations sur la publication:Drug Design, Development and Therapy, 4, page (291-297)
Statut de publication:Publié, 2010
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:α1A-blockers
Benign prostatic hyperplasia
Lower urinary tract symptoms
Silodosin
MeSH keywords:Adrenergic alpha-1 Receptor Antagonists -- adverse effects -- pharmacology -- therapeutic use
Disease Progression
Humans
Indoles -- adverse effects -- pharmacology -- therapeutic use
Male
Prostatic Hyperplasia -- drug therapy -- physiopathology
Prostatism -- drug therapy -- etiology
Receptors, Adrenergic, alpha-1 -- drug effects -- metabolism
Urination Disorders -- etiology
Note générale:Journal Article
Review
SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:1177-8881
info:doi/10.2147/DDDT.S10428
info:scp/79952483524
info:pmid/21116335
PMC2990389